CompletedNot Applicable

Novel Screening Modality for Early Gastric Cancer

Honduras120 participantsStarted 2019-10-01

Plain-language summary

Potential patients will be recruited at participating sites based on routine care with clinical indications for upper endoscopy. Following informed consent, patients will undergo their scheduled endoscopy with standard forceps biopsies along with the transepithelial brush samples. All samples, biopsy and brush samples, will be sent for pathology analysis, per standard clinical practice.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject is informed of the investigational nature of this study and given verbal and written informed consent in accordance with local, U.S., and international guidelines. * Both males and females at least 18 years. * Patients with clinical indications for upper endoscopy Exclusion Criteria: * Patients should not have an advanced medical or psychiatric conditions which that may limit their ability to participate in the study, as judged by the physician.

What they're measuring

Diagnostic yield of the WATS approach versus standard gastric biopsy mapping

Timeframe: 1-3 Years

Trial details

NCT IDNCT04114006

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-03-15

View on ClinicalTrials.gov More Gastric Cancer trials